abstract |
The application discloses a glycopeptide substituted with one or more substituents each comprising one or more phosphono groups, pharmaceutically acceptable salt, sterioisomer or a prodrug thereof. The above-mentioned glycopeptide can be utilised in a pharmaceutical composition along with a pharmaceutical acceptable carrier for the treatment of bacterial infection. |